Original Research
Published on 31 Jan 2024
Detection of potential safety signals related to the use of remdesivir and tocilizumab in the COVID era during pregnancy, resorting to open data from the FDA adverse event reporting system (FAERS)
in Pharmacoepidemiology
- 2,572 views
- 4 citations